The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults. Despite progress in surgical and medical neuro-oncology, prognosis for GBM patients remains dismal, with a median survival of only 14–15 months. The modest benefit of conventional therapies is due to the presence of GBM stem ce...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Ther Nucleic Acids
Egile Nagusiak: Affinito, Alessandra, Quintavalle, Cristina, Esposito, Carla Lucia, Roscigno, Giuseppina, Vilardo, Claudia, Nuzzo, Silvia, Ricci-Vitiani, Lucia, De Luca, Gabriele, Pallini, Roberto, Kichkailo, Anna S., Lapin, Ivan N., de Franciscis, Vittorio, Condorelli, Gerolama
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Gene & Cell Therapy 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796606/
https://ncbi.nlm.nih.gov/pubmed/31541799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2019.08.015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak